G01N 2333/4701
Details
G01N2333/4701 (Details) appears on 2,759 US grants and 5,364 published applications in this corpus.
Search patents in G01N- Granted patents
- 2,759
- Published applications
- 5,364
- Assignees
- 2,340
- Inventors
- 10,435
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1981 | 2 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 2 | 0 |
| 1987 | 1 | 0 |
| 1988 | 3 | 0 |
| 1989 | 1 | 0 |
| 1990 | 9 | 0 |
| 1991 | 2 | 0 |
| 1992 | 3 | 0 |
| 1993 | 8 | 0 |
| 1994 | 5 | 0 |
| 1995 | 13 | 0 |
| 1996 | 11 | 0 |
| 1997 | 31 | 0 |
| 1998 | 36 | 0 |
| 1999 | 46 | 0 |
| 2000 | 32 | 0 |
| 2001 | 55 | 16 |
| 2002 | 43 | 81 |
| 2003 | 40 | 124 |
| 2004 | 27 | 100 |
| 2005 | 30 | 107 |
| 2006 | 47 | 135 |
| 2007 | 36 | 150 |
| 2008 | 47 | 123 |
| 2009 | 52 | 201 |
| 2010 | 84 | 189 |
| 2011 | 92 | 231 |
| 2012 | 90 | 231 |
| 2013 | 104 | 233 |
| 2014 | 119 | 225 |
| 2015 | 158 | 383 |
| 2016 | 146 | 424 |
| 2017 | 192 | 296 |
| 2018 | 176 | 312 |
| 2019 | 184 | 242 |
| 2020 | 205 | 231 |
| 2021 | 147 | 248 |
| 2022 | 119 | 226 |
| 2023 | 81 | 198 |
| 2024 | 106 | 249 |
| 2025 | 93 | 243 |
| 2026 | 78 | 166 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- G01N 2333/4703RegulatorsIndexing code765
- G01N 2333/4709Amyloid plaque core proteinIndexing code502
- G01N 2333/4712Muscle proteinsIndexing code230
- G01N 2333/4737C-reactive proteinIndexing code193
- G01N 2333/4724LectinsIndexing code160
- G01N 2333/4716Complement proteinsIndexing code157
- G01N 2333/4727Calcium binding proteinsIndexing code120
- G01N 2333/4725MucinsIndexing code114
All 28 subgroupsShow fewer
- G01N 2333/4742KeratinIndexing code108
- G01N 2333/4719G-proteinsIndexing code74
- G01N 2333/471Pregnancy proteinsIndexing code66
- G01N 2333/4728Alpha-glycoproteinsIndexing code66
- G01N 2333/4745Insulin-like growth factor binding proteinIndexing code66
- G01N 2333/4748P53Indexing code53
- G01N 2333/4722ProteoglycansIndexing code52
- G01N 2333/4718LipocortinsIndexing code50
- G01N 2333/4739CyclinIndexing code48
- G01N 2333/4721Cationic antimicrobial peptidesIndexing code33
- G01N 2333/4713Plasma globulins, lactoglobulinIndexing code26
- G01N 2333/4715Cytokine-induced proteinsIndexing code20
- G01N 2333/4731CaseinIndexing code12
- G01N 2333/4736Retinoblastoma proteinIndexing code10
- G01N 2333/473RecogninsIndexing code6
- G01N 2333/474Pancreatic thread proteinIndexing code4
- G01N 2333/4733Acute pancreatitis-associated proteinIndexing code2
- G01N 2333/4734VillinIndexing code0
- G01N 2333/4743Bactericidal/permeability-increasing protein bpiIndexing code0
- G01N 2333/4746Cancer-associated scm-recognition factor, crisppIndexing code0
Recent patents
- Compositions, methods and kits for treating complement related disorders6 Oct 2026US 12,751,993 B2Trustees of Tufts College
- Integrated method for urinary prostate specific Antigen N-glycosylation profiling by capillary electrophoresis6 Oct 2026US 12,754,163 B2Pannon Egyetem
- Tau-binding antibodies29 Sep 2026US 12,747,288 B2Ucb Biopharma Srl
- Galectin-3 immunoassay22 Sep 2026US 12,742,787 B2BG Medicine, Inc.
- Accurate and comprehensive cardiac troponin I assay enabled by nanotechnology and proteomics22 Sep 2026US 12,744,137 B2Wisconsin Alumni Research Foundation
- Method for isolating fetuin-a8 Oct 2026US 2026/0308213 A1PreviPharma GmbH
- Electrochemical biosensors, systems, and methods of use8 Oct 2026US 2026/0309671 A1
- Identifying antibody virus-neutralization status8 Oct 2026US 2026/0309711 A1
- Compositions and methods for detection of aberrant cdk5 expression8 Oct 2026US 2026/0309712 A1Arizona Board of Regents on Behalf of the University of Arizona
- A nasal fluid sample comprising abeta, ptau and/or ttau8 Oct 2026US 2026/0309725 A1Noselab GmbH
Most cited
By later US patents
- Focusing of microparticles in microfluidic systems442US 6,592,821 B1Caliper Technologies Corp. · 2003
- Focusing of microparticles in microfluidic systems377US 6,506,609 B1Caliper Technologies Corp. · 2003
- Methods for the detection of soluble .beta.-amyloid peptide244US 5,593,846 AAthena Neurosciences, Inc. · 1997
- Methods for monitoring cellular processing of .beta.-amyloid precursor protein167US 5,441,870 AAthena Neurosciences, Inc. · 1995
- Methods for predicting drug response156US 5,824,467 ACeltrix Pharmaceuticals, Inc. · 1998